Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T17:03:34.757Z.
Calculation as of: 2026-10-06T17:03:34.757Z.
Quote observation: 2026-10-06T17:00:50.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4efcc2f75e7b9d1a3dd193370b83b229becf15f1f7fcdbde4bbae966de3ea950
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Olema Pharmaceuticals, Inc.
Market Cap
$706.51M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$702.89M
EV/EBIT Ratio
N/A
TTM Avg
877.08x
3Y Avg
871.89x
5Y Avg
871.89x
Market Cap
$714.52M
EV/EBIT Ratio
9.10x
TTM Avg
12.78x
3Y Avg
12.26x
5Y Avg
15.40x
Market Cap
$717.39M
EV/EBIT Ratio
N/A
TTM Avg
501.20x
3Y Avg
422.57x
5Y Avg
422.57x
Market Cap
$688.65M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$730.28M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | $706.51M | N/A | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $702.89M | N/A | 877.08x | 871.89x | 871.89x |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $714.52M | 9.10x | 12.78x | 12.26x | 15.40x |
| Cytek Biosciences, Inc. (CTKB)vs › | $717.39M | N/A | 501.20x | 422.57x | 422.57x |
| ArriVent BioPharma, Inc. (AVBP)vs › | $718.19M | N/A | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $688.65M | N/A | N/A | N/A | N/A |
| Solid Biosciences Inc. (SLDB)vs › | $682.75M | N/A | N/A | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $730.28M | N/A | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $737.10M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $674.61M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
